Community-based clinical trial
Community-based clinical trials are clinical trials conducted directly through doctors and clinics rather than academic research facilities. They are designed to be administered through primary care physicians, community health centers and local outpatient facilities. In 1986, the Community Consortium held the first such trials in the United States to determine the efficiency of preventive treatments after the onset of Pneumocystis pneumonia.[1] The trials give patients access to new medications and keep doctors involved with new developments in research. However, critics state that drug company payments to doctors for patients enrolled in such studies present a conflict of interest and potential for abuse.[2][3] Community-based trials are becoming prevalent in human-testing stage pharmaceutical research.
See also
[edit]References
[edit]- ^ University of Texas Medical Branch, AIDS Clinical Trials Unit, "History of CABs"
- ^ Phyllis Maguire (July–August 1999). "Community-based trials under scrutiny". ACP-ASIM Observer. Archived from the original on 2007-05-26. Retrieved 2007-03-07.
- ^ Silversides A (January 2004). "The tribulations of community-based trials". CMAJ. 170 (1): 33. PMC 305306. PMID 14707212.
External links
[edit]- The Community Programs for Clinical Research on AIDS
- Jackson FM (April 2002). "Considerations for community-based research with African American women". Am J Public Health. 92 (4): 561–4. doi:10.2105/AJPH.92.4.561. PMC 1447117. PMID 11919052.
 | This medical article is a stub. You can help Wikipedia by expanding it. |